TrialJournal of clinical oncology : official journal of the American Society of Clinical Oncology2025

Olaparib as Treatment Versus Nonplatinum Chemotherapy in Patients With Platinum-Sensitive Relapsed Ovarian Cancer: Phase III SOLO3 Study Final Overall Survival Results.

Giovanni Scambia et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.